Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 41
2022 3
2023 2
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34857596

47 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccine-induced cellulitis and myositis.
Ramalingam S, Arora H, Lewis S, Gunasekaran K, Muruganandam M, Nagaraju S, Padmanabhan P. Ramalingam S, et al. Cleve Clin J Med. 2021 Dec 2;88(12):648-650. doi: 10.3949/ccjm.88a.21038. Cleve Clin J Med. 2021. PMID: 34857596 Free article. No abstract available.
COVID-19 vaccine-related myositis.
Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. Theodorou DJ, et al. QJM. 2021 Oct 7;114(6):424-425. doi: 10.1093/qjmed/hcab043. QJM. 2021. PMID: 33647971 Free PMC article. No abstract available.
SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M, Nader ND. Mahmoodpoor A, et al. Immunol Invest. 2021 Oct;50(7):802-809. doi: 10.1080/08820139.2021.1936009. Epub 2021 Jun 10. Immunol Invest. 2021. PMID: 34109900 Free PMC article. Review.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S, Pilishvili T, Derado G, Soe MM, Dollard P, Wu H, Li Q, Bagchi S, Dubendris H, Link-Gelles R, Jernigan JA, Budnitz D, Bell J, Benin A, Shang N, Edwards JR, Verani JR, Schrag SJ. Nanduri S, et al. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437519 Free PMC article.
Immune imprinting and SARS-CoV-2 vaccine design.
Wheatley AK, Fox A, Tan HX, Juno JA, Davenport MP, Subbarao K, Kent SJ. Wheatley AK, et al. Trends Immunol. 2021 Nov;42(11):956-959. doi: 10.1016/j.it.2021.09.001. Epub 2021 Sep 15. Trends Immunol. 2021. PMID: 34580004 Free PMC article.
SARS-CoV-2 vaccine candidates in rapid development.
Li L, Guo P, Zhang X, Yu Z, Zhang W, Sun H. Li L, et al. Hum Vaccin Immunother. 2021 Mar 4;17(3):644-653. doi: 10.1080/21645515.2020.1804777. Epub 2020 Oct 29. Hum Vaccin Immunother. 2021. PMID: 33121319 Free PMC article. Review.
47 results